Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics 1 Year Total Returns (Daily) : 175.4% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 175.4% |
| August 20, 2026 | 168.0% |
| August 19, 2026 | 175.4% |
| August 18, 2026 | 179.9% |
| August 17, 2026 | 182.9% |
| August 14, 2026 | 182.1% |
| August 13, 2026 | 167.0% |
| August 12, 2026 | 178.8% |
| August 11, 2026 | 175.9% |
| August 10, 2026 | 193.7% |
| August 07, 2026 | 186.2% |
| August 06, 2026 | 171.4% |
| August 05, 2026 | 154.8% |
| August 04, 2026 | 152.3% |
| August 03, 2026 | 145.7% |
| July 31, 2026 | 153.7% |
| July 30, 2026 | 153.8% |
| July 29, 2026 | 141.8% |
| July 28, 2026 | 143.2% |
| July 27, 2026 | 145.8% |
| July 24, 2026 | 153.3% |
| July 23, 2026 | 149.9% |
| July 22, 2026 | 146.3% |
| July 21, 2026 | 150.5% |
| July 20, 2026 | 142.0% |
| Date | Value |
|---|---|
| July 17, 2026 | 149.7% |
| July 16, 2026 | 133.1% |
| July 15, 2026 | 144.9% |
| July 14, 2026 | 137.7% |
| July 13, 2026 | 145.1% |
| July 10, 2026 | 148.8% |
| July 09, 2026 | 163.2% |
| July 08, 2026 | 181.8% |
| July 07, 2026 | 182.4% |
| July 06, 2026 | 157.6% |
| July 02, 2026 | 159.7% |
| July 01, 2026 | 149.3% |
| June 30, 2026 | 121.8% |
| June 29, 2026 | 118.4% |
| June 26, 2026 | 120.7% |
| June 25, 2026 | 125.3% |
| June 24, 2026 | 127.6% |
| June 23, 2026 | 122.9% |
| June 22, 2026 | 115.7% |
| June 18, 2026 | 109.3% |
| June 17, 2026 | 101.8% |
| June 16, 2026 | 102.4% |
| June 15, 2026 | 99.50% |
| June 12, 2026 | 94.92% |
| June 11, 2026 | 98.39% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences, Inc. | 29.10% |
| Insmed, Inc. | -5.15% |
| Madrigal Pharmaceuticals, Inc. | 26.94% |
| AbbVie, Inc. | 30.40% |
| PTC Therapeutics, Inc. | 42.72% |